Genetic influence of the nonclassical major histocompatibility complex class I molecule MICB in multiple sclerosis susceptibility

Tissue Antigens

Volumn 72, Issue 1, 2008, Pages 54-59

  Fernandez Morera, J L ^a   Rodriguez Rodero, S ^a   Tunon, A ^a   Martinez Borra, J ^a   Vidal Castineira, J R ^a   Lopez Vazquez, A ^a   Rodrigo, L ^a   Rodrigo, P ^b   Gonzalez S ^b   Lahoz, C H ^a   Lopez Larrea, C ^a  

^a HOSPITAL UNIVERSITARIO CENTRAL DE ASTURIAS   (Spain)

^b UNIVERSITY OF OVIEDO   (Spain)

Author keywords

Major histocompatibility complex class I; Major histocompatibility complex class II; MHC class I chain related gene B; Multiple sclerosis; NKG2D

Indexed keywords

HLA A ANTIGEN; HLA B ANTIGEN; HLA DR ANTIGEN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2;

ADULT; ALLELE; ARTICLE; CONFIDENCE INTERVAL; DISEASE PREDISPOSITION; FEMALE; GENE FREQUENCY; GENETIC RISK; GENETIC SUSCEPTIBILITY; HAPLOTYPE; HUMAN; MAJOR CLINICAL STUDY; MAJOR HISTOCOMPATIBILITY COMPLEX; MALE; MULTIPLE SCLEROSIS; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR;

ADULT; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; HISTOCOMPATIBILITY ANTIGENS CLASS I; HLA-B ANTIGENS; HLA-DR ANTIGENS; HUMANS; MALE; MULTIPLE SCLEROSIS;

EID: 45249123864     PISSN: 00012815     EISSN: 13990039     Source Type: Journal    
DOI: 10.1111/j.1399-0039.2008.01066.x     Document Type: Article

References (34)

1. Noseworthy JH, Lucchinetti C, Rodriguez M, Weinshenker BG. Multiple sclerosis. N Engl J Med 2000 : 343 : 938 52.
2. Compston A, Coles A. Multiple sclerosis. Lancet 2002 : 359 : 1221 31.
3. Haines JL, Ter-Minassian M, Bazyk A et al. A complete genomic screen for multiple sclerosis underscores a role for the major histocompatibility complex. The Multiple Sclerosis Genetics Group. Nat Genet 1996 : 13 : 469 71.
4. Hillert J. Human leukocyte antigen studies in multiple sclerosis. Ann Neurol 1994 : 36 (Suppl S15 7.
5. Allen M, Sandberg-Wollheim M, Sjogren K, Erlich HA, Petterson U, Gyllensten T. Association of susceptibility to multiple sclerosis in Sweden with HLA class II DRB1 and DQB1 alleles. Hum Immunol 1994 : 39 : 41 8.
6. Marrosu MG, Murru MR, Costa G et al. Multiple sclerosis in Sardinia is associated and in linkage disequilibrium with HLA-DR3 and -DR4 alleles. Am J Hum Genet 1997 : 61 : 454 7.
7. Marrosu MG, Murru MR, Costa G, Murru R, Muntoni F, Cucca F. DRB1-DQA1-DQB1 loci and multiple sclerosis predisposition in the Sardinian population. Hum Mol Genet 1998 : 7 : 1235 7.
8. Tiwari JL, Terasaki PI. HLA and Disease Associations. New York : Springer-Verlag Inc, 1985.
9. Fogdell-Hahn A, Ligers A, Gronning M, Hillert J, Olerup O. Multiple sclerosis: a modifying influence of HLA class I genes in an HLA class II associated autoimmune disease. Tissue Antigens 2000 : 55 : 140 8.
10. Harbo HF, Lie BA, Sawcer S et al. Genes in the HLA class I region may contribute to the HLA class II-associated genetic susceptibility to multiple sclerosis. Tissue Antigens 2004 : 63 : 237 47.
11. Yeo TW, De Jager PL, Gregory SG et al. A second major histocompatibility complex susceptibility locus for multiple sclerosis. Ann Neurol 2007 : 61 : 228 36.
12. Bahram S, Bresnahan M, Geraghty DE, Spies T. A second lineage of mammalian histocompatibility complex class I genes. Proc Natl Acad Sci U S A 1994 : 91 : 6259 63.
13. Bauer S, Groh V, Wu J et al. Activation of NK cells and T cells by NKG2D, a receptor for stress-inducible MICA. Science 1999 : 285 : 727 9.
14. Lucchinetti C, Bruck W, Parisi J, Scheithauer B, Rodriguez M, Lassmann H. A quantitative analysis of oligodendrocytes in multiple sclerosis lesions. A study of 113 cases. Brain 1999 : 122 : 2279 95.
15. Lopez-Larrea C, Uria DF, Coto E. HLA antigens in multiple sclerosis of a northern Spanish population. J Neurol Neurosurg Psychiatry 1990 : 53 : 434 5.
16. Fdez-Morera JL, Tunon A, Rodríguez-Rodero S et al. Clinical behaviour of multiple sclerosis is modulated by the MHC class I-chain related gene A. Tissue Antigens 2006 : 67 : 409 14.
17. Gonzalez S, Martinez-Borra J, Torre-Alonso JC et al. The MICA-A9 triplet repeat polymorphism in the transmembrane region confers additional susceptibility to the development of psoriatic arthritis and is independent of the association of Cw*0602 in psoriasis. Arthritis Rheum 1999 : 42 : 1010 6.
18. Lopez Vazquez A, Rodrigo L, Fuentes D et al. MICA gene polymorphism modulates the development of celiac disease in patients with the high-risk heterodimer DQA1*0501/DQB1*0201. Gut 2002 : 50 : 336 40.
19. Fdez-Morera JL, Rodrigo L, Lopez-Vazquez A et al. MHC class I chain-related gene A transmembrane polymorphism modulates the extension of ulcerative colitis. Hum Immunol 2003 : 64 : 816 22.
20. Gonzalez S, Rodrigo L, Lopez-Vazquez A et al. Association of MHC class I related gene B (MICB) to celiac disease. Am J Gastroenterol 2004 : 99 : 676 80.
21. Rodriguez-Rodero S, Rodrigo L, Fdez-Morera JL et al. MHC class I chain-related gene B promoter polymorphisms and celiac disease. Hum Immunol 2006 : 67 : 208 14.
22. Groh V, Bruhl A, El-Gabalawy H, Nelson JL, Spies T. Stimulation of T cell autoreactivity by anomalous expression of NKG2D and its MIC ligands in rheumatoid arthritis. Proc Natl Acad Sci U S A 2003 : 100 : 9452 7.
23. Ogasawara K, Hamerman JA, Ehrlich LR et al. NKG2D blockade prevents autoimmune diabetes in NOD mice. Immunity 2004 : 20 : 757 67.
24. Hue S, Mention JJ, Monteiro RC et al. A direct role for NKG2D/MICA interaction in villous atrophy during celiac disease. Immunity 2004 : 21 : 367 77.
25. Meresse B, Chen Z, Ciszewski C et al. Coordinated induction by IL15 of a TCR-independent NKG2D signaling pathway converts CTL into lymphokine-activated killer cells in celiac disease. Immunity 2004 : 21 : 57 66.
26. Seko Y, Sugishita K, Sato O et al. Expression of costimulatory molecules (4-1BBL and Fas) and major histocompatibility class I chain-related A (MICA) in aortic tissue with Takayasu's arteritis. J Vasc Res 2004 : 41 : 84 90.
27. Saikali P, Antel JP, Newcombe J et al. NKG2D-mediated cytotoxicity toward oligodendrocytes suggests a mechanism for tissue injury in multiple sclerosis. J Neurosci 2007 : 27 : 1220 8.
28. McDonald WI, Compston A, Edan G et al. Recommended diagnostic criteria for multiple sclerosis: guidelines from the International Panel on the diagnosis of multiple sclerosis. Ann Neurol 2001 : 50 : 121 7.
29. Kurtzke JF. Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS). Neurology 1988 : 33 : 1444 52.
30. Gonzalez S, Rodriguez-Rodero S, Martinez-Borra J, Lopez-Vazquez A, Rodrigo L, Lopez-Larrea C. MICB typing by PCR amplification with sequence specific primers. Immunogenetics 2003 : 54 : 850 5.
31. Marsh SG WHO Nomenclature Committee for Factors of the HLA System. Nomenclature for factors of the HLA system, update September 2005. Hum Immunol 2005 : 66 : 1189 91.
32. Brynedal B, Duvefelt K, Jonasdottir G et al. HLA-A confers an HLA-DRB1 independent influence on the risk of multiple sclerosis. PLoS ONE 2007 : 2 : e664.
33. Lopez-Arbesu R, Ballina-Garcia FJ, Alperi-Lopez M et al. MHC class I chain-related gene B (MICB) is associated with rheumatoid arthritis susceptibility. Rheumatology (Oxford) 2007 : 46 : 426 30.
34. Rodriguez-Rodero S, Gonzalez S, Rodrigo L et al. Transcriptional regulation of MICA and MICB: a novel polymorphism in MICB promoter alters transcriptional regulation by Sp1. Eur J Immunol 2007 : 37 : 1938 53.